Vanda Pharmaceuticals (VNDA) Change in Receivables (2010 - 2026)
Vanda Pharmaceuticals recorded quarterly Change in Receivables of $2.3 million in Q1 2026, down 42.75% quarter-over-quarter from $4.1 million in Q4 2025, and up 192.07% year-over-year from $798786.9 in Q1 2025.
Vanda Pharmaceuticals' Change in Receivables history runs 17 years deep, the most recent figure standing at $2.3 million for Q1 2026.
- In Q1 2026, Change in Receivables rose 192.07% year-over-year to $2.3 million; the TTM figure through Mar 2026 stood at $12.3 million (up 56.25% YoY), while the FY2025 annual figure was $7.5 million, down 42.65% from the prior year.
- Change in Receivables came in at $2.3 million for Q1 2026 at Vanda Pharmaceuticals, down from $4.1 million in the prior quarter.
- In the past five years, Change in Receivables ranged from a high of $9.1 million in Q2 2023 to a low of -$8.9 million in Q1 2023.
- A 5-year average of $1.4 million and a median of $2.3 million in 2026 frame the typical range for Change in Receivables.
- On a YoY basis, Change in Receivables climbed as much as 662.42% in 2023 and fell as far as 829.85% in 2023.
- Vanda Pharmaceuticals' Change in Receivables stood at $4.1 million in 2022, then increased by 18.79% to $4.8 million in 2023, then declined by 8.37% to $4.4 million in 2024, then declined by 8.03% to $4.1 million in 2025, then tumbled by 42.75% to $2.3 million in 2026.
- According to Business Quant data, Change in Receivables over the past three periods registered $2.3 million, $4.1 million, and $5.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 208,524.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | -39.80 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -1.20 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 110.42 Mn |
| 10 | Vanda Pharmaceuticals | 379.35 Mn | 177.04 Mn | 48.56 Mn | 2.33 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.33 Mn |
| Mar 31, 2026 | 2.33 Mn |
| Dec 31, 2025 | 4.08 Mn |
| Dec 31, 2025 | 4.08 Mn |
| Sep 30, 2025 | 5.57 Mn |
| Sep 30, 2025 | 5.57 Mn |
| Jun 30, 2025 | 353,000.00 |
| Jun 30, 2025 | 353,000.00 |
| Mar 31, 2025 | -2.53 Mn |
| Mar 31, 2025 | -2.53 Mn |
| Dec 31, 2024 | 4.43 Mn |
| Dec 31, 2024 | 4.43 Mn |
| Sep 30, 2024 | 830,000.00 |
| Sep 30, 2024 | 830,000.00 |
| Jun 30, 2024 | 5.16 Mn |
| Jun 30, 2024 | 5.16 Mn |
| Mar 31, 2024 | 2.59 Mn |
| Mar 31, 2024 | 2.59 Mn |
| Dec 31, 2023 | 4.84 Mn |
| Dec 31, 2023 | 4.84 Mn |
| Sep 30, 2023 | -4.33 Mn |
| Sep 30, 2023 | -4.33 Mn |
| Jun 30, 2023 | 9.10 Mn |
| Jun 30, 2023 | 9.10 Mn |
| Mar 31, 2023 | -8.90 Mn |
| Mar 31, 2023 | -8.90 Mn |
| Dec 31, 2022 | 4.07 Mn |
| Dec 31, 2022 | 4.07 Mn |
| Sep 30, 2022 | 593,000.00 |
| Sep 30, 2022 | 593,000.00 |
| Jun 30, 2022 | -1.62 Mn |
| Jun 30, 2022 | -1.62 Mn |
| Mar 31, 2022 | -1.96 Mn |
| Mar 31, 2022 | -1.96 Mn |
| Dec 31, 2021 | -9.02 Mn |
| Dec 31, 2021 | -9.02 Mn |
| Sep 30, 2021 | 4.42 Mn |
| Sep 30, 2021 | 4.42 Mn |
| Jun 30, 2021 | 5.58 Mn |
| Jun 30, 2021 | 5.58 Mn |
| Mar 31, 2021 | 1.48 Mn |
| Mar 31, 2021 | 1.48 Mn |
| Dec 31, 2020 | 1.99 Mn |
| Dec 31, 2020 | 1.99 Mn |
| Sep 30, 2020 | 3.45 Mn |
| Sep 30, 2020 | 3.45 Mn |
| Jun 30, 2020 | -4.58 Mn |
| Jun 30, 2020 | -4.58 Mn |
| Mar 31, 2020 | 2.91 Mn |
| Mar 31, 2020 | 2.91 Mn |
| Dec 31, 2019 | -428,000.00 |
| Dec 31, 2019 | -428,000.00 |
| Sep 30, 2019 | 2.94 Mn |
| Sep 30, 2019 | 2.94 Mn |
| Jun 30, 2019 | -2.42 Mn |
| Jun 30, 2019 | -2.42 Mn |
| Mar 31, 2019 | -2.43 Mn |
| Mar 31, 2019 | -2.43 Mn |
| Dec 31, 2018 | 3.52 Mn |
| Dec 31, 2018 | 3.52 Mn |
| Sep 30, 2018 | 392,000.00 |
| Sep 30, 2018 | 392,000.00 |
| Jun 30, 2018 | 1.58 Mn |
| Jun 30, 2018 | 1.58 Mn |
| Mar 31, 2018 | 5.71 Mn |
| Mar 31, 2018 | 5.71 Mn |
| Dec 31, 2017 | -436,000.00 |
| Dec 31, 2017 | -436,000.00 |
| Sep 30, 2017 | -2.85 Mn |
| Sep 30, 2017 | -2.85 Mn |
| Jun 30, 2017 | 3.27 Mn |
| Jun 30, 2017 | 3.27 Mn |
| Mar 31, 2017 | -2.52 Mn |
| Mar 31, 2017 | -2.52 Mn |
| Dec 31, 2016 | 4.35 Mn |
| Dec 31, 2016 | 4.35 Mn |
| Sep 30, 2016 | 2.02 Mn |
| Sep 30, 2016 | 2.02 Mn |
| Jun 30, 2016 | -2.42 Mn |
| Jun 30, 2016 | -2.42 Mn |
| Mar 31, 2016 | 348,000.00 |
| Mar 31, 2016 | 348,000.00 |
| Dec 31, 2015 | 542,000.00 |
| Dec 31, 2015 | 542,000.00 |
| Sep 30, 2015 | -29,000.00 |
| Sep 30, 2015 | -29,000.00 |
| Jun 30, 2015 | -4.30 Mn |
| Jun 30, 2015 | -4.30 Mn |
| Mar 31, 2015 | 16.47 Mn |
| Mar 31, 2015 | 16.47 Mn |
| Dec 31, 2014 | -42,000.00 |
| Dec 31, 2014 | -42,000.00 |
| Sep 30, 2014 | 1.32 Mn |
| Sep 30, 2014 | 1.32 Mn |
| Jun 30, 2014 | 685,000.00 |
| Jun 30, 2014 | 685,000.00 |
| Mar 31, 2014 | -340,000.00 |
| Mar 31, 2014 | -340,000.00 |
| Dec 31, 2013 | 75,000.00 |
| Dec 31, 2013 | 75,000.00 |
| Sep 30, 2013 | 315,000.00 |
| Sep 30, 2013 | 315,000.00 |
| Jun 30, 2013 | 179,000.00 |
| Jun 30, 2013 | 179,000.00 |
| Mar 31, 2013 | 294,000.00 |
| Mar 31, 2013 | 294,000.00 |
| Dec 31, 2012 | -367,000.00 |
| Dec 31, 2012 | -367,000.00 |
| Sep 30, 2012 | -165,000.00 |
| Sep 30, 2012 | -165,000.00 |
| Jun 30, 2012 | 165,000.00 |
| Jun 30, 2012 | 165,000.00 |
| Mar 31, 2012 | -83,000.00 |
| Mar 31, 2012 | -83,000.00 |
| Dec 31, 2011 | 402,000.00 |
| Dec 31, 2011 | 402,000.00 |
| Sep 30, 2011 | 464,000.00 |
| Sep 30, 2011 | 464,000.00 |
| Jun 30, 2011 | -143,000.00 |
| Jun 30, 2011 | -143,000.00 |
| Mar 31, 2011 | 384,000.00 |
| Mar 31, 2011 | 384,000.00 |
| Dec 31, 2010 | 17,000.00 |
| Dec 31, 2010 | 17,000.00 |
| Sep 30, 2010 | -161,000.00 |
| Sep 30, 2010 | -161,000.00 |